Nikkei Biotech published an article about our company 2022 1/12 MEDIA January 12, 2022August 8, 2026 about us in "Nikkei Biotech"Articlepublished MEDIA Execution of a license agreement for a substance with immunostimulatory properties and implementation of a third-party allocation of new shares in the seed round HISHOH Biopharma was introduced on the LINK-J website. Author of this article Hishoh Related Articles HISHOH Biopharma was introduced on the LINK-J website. March 6, 2023
